TIABLO WIPES (OCULAR SURGERY AND BLEPHARITIS, EYELID CLEANING)

The product has been specifically formulated as an adjuvant in blepharitis treatment. This product contains a derivative of Tea Tree Oil (Terpinen-4-ol) characterized by an anti-inflammatory, antimicrobial and acaricidal activity against Staphylococcus aureus and Demodex (either directly or by carrying...

Game changer FDC with Levofloxacin, a fluoroquinolone with a broad spectrum of action and activity on bacteria (Gram+ and Gram-) most frequently implicated in ocular infections, and ketorolac, NSAID with powerful anti-inflammatory effect and analgesic effect. Phase II studies completed.

...

First in class combination of a quinolone and a steroid for the treatment of Otitis externa and Media with Perforated Tympanic Membrane supported by phase III clinical study performed at European level. Please contact us for more information and to discuss partnership on a global scale. Presentation: ...

First innovative colonoscopy preparation that allows the patient to be prepared on the same day of colonoscopy. The reconstituted solution has a slightly sugary taste recognized as very pleasant by patients, it’s easy to take and it requires only 750 ml of water, improving patient compliance with treat...

The efficacy of the TiAB complex is NOW available in a new GREEN cap, derived from sustainable red seaweed based carrageenan, for all those consumers seeking an animal free alternative. The NEW TiAB Soft VEGICAPS formulation is indicated as adjuvant in the treatment of bacterial, fungal and viral infection...

Biovaginil is a food supplement with Lactobacillus Crispatus and vitamin A.  L. Crispatus is a specific probiotic strains with a clear indication (NTCVAG04) that strongly correlates with the absence of Bacterial Vaginitis and is the only Lactobacillus species associated with low pH, negative whiff...

Levofloxacin-Dexamethasone eye drops solution is the first combination approved for the management of patients undergoing cataract surgery able to prevent infection and ensure complete control of inflammation with one week treatment. Levofloxacin-Dexamethasone combines the power of the most ac...

Ededay and Edenight are hypertonic products containing sodium hyaluronate 0.4% and hypertonic agents, indicated for the temporary relief of the symptoms of corneal edema. Ededay eye drops also contains sorbitol (13,5%) and can be used during the day.          Ed...

Allergix Free and Lertal spray are lubricating and lenitive ocular spray, containing liposomes, Perilla and sodium hyaluronate, three natural compounds with synergistic action for treating inflammation and allergic conjunctivitis symptoms. The combined action of liposomes and sodium hyaluronate helps t...

NTC S.r.l. offers a wide range of ophthalmic medical devices which includes hyaluronic acid at different dosages 0.10%, 0.15%, 0.2%, 0.4% and the addition of other components.
LUVIS:  Hyaluronic Acid eye drop solution is the ideal product for instantly soothing and hydrating dry eyes. Sodium Hyal...

Dexamethasone is a long-acting synthetic adrenocorticoid with intense anti-inflammatory activity Thanks to its properties, dexamethasone is useful in the management of steroid-responsive inflammatory conditions such as uveitis, allergic conjunctivitis, iritis, or cyclitis; symptomatic treatment of cor...

Ofloxacin is a second-generation fluoroquinolone. Levofloxacin is a third-generation fluoroquinolone and is the pure L-enantiomer of ofloxacin. 
Fluoroquinolones are broad spectrum bactericidal agents with activity against many of the important corneal pathogens including staphylococci, Ne...

A pharmacovigilance study published confirms the safety of fixed-dose eye drops for post-cataract surgery 17 Jul, 2025A recently published five-year pharmacovigilance study confirms the excellent safety profile of a fixed-dose combination eye drop containing an anti-inflammatory steroid and a quinolone antibiotic, developed by NTC, indicated for the prevention and treatment of inflammation and prevention of infection following cataract surgery in adults. The study was submitted when nearly 4 million patients across about 60 countries worldwide were treated with this drug.

 

Advanced scientific research and technology drive our efforts to innovate care practices.
Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
Our research aims to put pioneering new products within the reach of everyone and to optimize the
performance of our products by analyzing the daily needs and habits of people undergoing treatment.
We research, develop and produce innovative drugs, medical devices and food supplements.
We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.

A new in vitro study shows that a 2% concentration of TiAB—a compound based on silver-bound titanium dioxide—is sufficient to exert strong bactericidal activity within 24 hours against Gram-negative bacteria and support wound healing.

It describes our 2024 journey

Our products 

NTC: Novelty

NTC Technology

NTC Care